JP2003164290A5 - - Google Patents

Info

Publication number

JP2003164290A5

JP2003164290A5 JP2001367093A JP2001367093A JP2003164290A5 JP 2003164290 A5 JP2003164290 A5 JP 2003164290A5 JP 2001367093 A JP2001367093 A JP 2001367093A JP 2001367093 A JP2001367093 A JP 2001367093A JP 2003164290 A5 JP2003164290 A5 JP 2003164290A5

Authority

JP

Japan

Prior art keywords

dna

complementary strand

cell

polypeptide

recombinant vector

Prior art date

2001-11-30

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 108020004414 DNA Proteins 0.000 claims description 46
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 30
• 229920001184 polypeptide Polymers 0.000 claims description 25
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 25
• 230000000295 complement effect Effects 0.000 claims description 21
• 210000004027 cell Anatomy 0.000 claims description 18
• 239000013612 plasmid Substances 0.000 claims description 16
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 13
• 230000009711 regulatory function Effects 0.000 claims description 11
• 230000017455 cell-cell adhesion Effects 0.000 claims description 7
• 210000002744 extracellular matrix Anatomy 0.000 claims description 7
• 208000024827 Alzheimer disease Diseases 0.000 claims description 6
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims description 6
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims description 6
• 230000006870 function Effects 0.000 claims description 6
• 239000011159 matrix material Substances 0.000 claims description 4
• 238000007792 addition Methods 0.000 claims description 3
• 230000037430 deletion Effects 0.000 claims description 3
• 238000012217 deletion Methods 0.000 claims description 3
• 230000035772 mutation Effects 0.000 claims description 3
• 238000006467 substitution reaction Methods 0.000 claims description 3
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
• 238000000034 method Methods 0.000 claims description 2
• 201000010099 disease Diseases 0.000 claims 3
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
• 239000003814 drug Substances 0.000 claims 3
• 238000010998 test method Methods 0.000 claims 3
• 238000012360 testing method Methods 0.000 claims 3
• 230000030833 cell death Effects 0.000 claims 2
• 238000007689 inspection Methods 0.000 claims 2
• 210000002569 neuron Anatomy 0.000 claims 2
• 239000008194 pharmaceutical composition Substances 0.000 claims 2
• 230000003449 preventive effect Effects 0.000 claims 2
• 229940124597 therapeutic agent Drugs 0.000 claims 2
• 239000003153 chemical reaction reagent Substances 0.000 claims 1
• 150000001875 compounds Chemical class 0.000 claims 1
• 238000012258 culturing Methods 0.000 claims 1
• 229940079593 drug Drugs 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 230000016273 neuron death Effects 0.000 claims 1
• 230000002265 prevention Effects 0.000 claims 1
• 101100075438 Rattus norvegicus Lrrc15 gene Proteins 0.000 description 6
• 210000004556 brain Anatomy 0.000 description 4
• 230000014509 gene expression Effects 0.000 description 4
• 108090000623 proteins and genes Proteins 0.000 description 4
• 239000002299 complementary DNA Substances 0.000 description 3
• 101001039113 Homo sapiens Leucine-rich repeat-containing protein 15 Proteins 0.000 description 2
• 206010061218 Inflammation Diseases 0.000 description 2
• 102000043361 human LRRC15 Human genes 0.000 description 2
• 230000004054 inflammatory process Effects 0.000 description 2
• 210000004498 neuroglial cell Anatomy 0.000 description 2
• 230000001105 regulatory effect Effects 0.000 description 2
• 210000001519 tissue Anatomy 0.000 description 2
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
• 206010003571 Astrocytoma Diseases 0.000 description 1
• 108090000695 Cytokines Proteins 0.000 description 1
• 102000004127 Cytokines Human genes 0.000 description 1
• 102100037850 Interferon gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 208000012902 Nervous system disease Diseases 0.000 description 1
• 208000025966 Neurological disease Diseases 0.000 description 1
• 238000000636 Northern blotting Methods 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 239000000470 constituent Substances 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 230000006866 deterioration Effects 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 238000002372 labelling Methods 0.000 description 1
• 108020004999 messenger RNA Proteins 0.000 description 1
• 210000002826 placenta Anatomy 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 108010054624 red fluorescent protein Proteins 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 230000010474 transient expression Effects 0.000 description 1